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randomised trial of general practitioner practices. Patients were
over 74 years old, living in the community, in the UK. Costs and
outcomes were discounted (3.5% recommended UK rate).
Missing data for censored cases were imputed by survival analy-
sis. Missing data due to missing observations were imputed by
characteristic of patient. Data were adjusted for age, gender and
cluster randomisation. Costs and LYGs were bootstrapped. Net
beneﬁt statistics were estimated. Cost-effectiveness acceptabil-
ity analysis used willingness to pay thresholds (GBP0 to
GBP50000). Sensitivity analysis assessed the impact of structural
factors and assumptions. RESULTS: 109 GP practices were
assigned to (a) assessment method: UA = 55 (21,762 patients)
TA = 54 (21,457 patients); (b) management method: GM = 55
(22,216 patients); PC = 54 (21,003 patients). Preliminary analy-
sis indicated a net cost to TA (GBP296; 2.5–97.5 percentile
GBP140-GBP448 ) versus UA and a net saving to PC (-GBP41;
2.5–97.5 percentile -GBP192-GBP107) versus GM. LYGs were
TA (0.006; 2.5–97.5 percentile -0.006–0.19) and PC (0.016;
2.5–97.5 percentile 0.004–0.28). The probability of net beneﬁt
was 0–0.50 for TA across the willingness to pay thresholds. The
probability of net beneﬁt for PC was 0.70–1.00. Sensitivity
analysis indicated the results for targeted assessment, but not PC,
were sensitive to method of imputing missing data and time-
frame. CONCLUSIONS: The cost-effectiveness of targeted
assessment is uncertain. PC management appears cost effective
in the primary and sensitivity analyses. The small cost and effect
differences between strategies indicate cost-effective conﬁgura-
tion of services may be driven primarily by local considerations.
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OBJECTIVES: Analysis of participation on drug costs in seniors
in the Czech Republic in connection with seniors’ social status
(e.g. ﬁnancial, household conditions). METHODS: Quota-
sampled questionnaire-based interview with 450 respondents
visiting pharmacy; Ratio men: women approximately 1 :2; Age
60 years old and elder; 3 regions of the Czech Republic.
RESULTS: Most of respondents (60%) live in households with
their partners. Respondent’s income was retirement pension in
80%. Its average level was between 5001 and 7499CZK.
Respondents used together 1651 medicines on physician’s pre-
scription in last four weeks. Overall co-payment for medicines
was 31,944CZK, e.g. 70CZK per patient. Only 27% of respon-
dents used fully reimbursed products. Respondents used together
273 OTC drugs in value of 12,900CZK, e.g. 29CZK per patient.
Average respondents spent on medicines 100CZK in last four
weeks, e.g. between 2 and 1.3% of their income. There were
respondents, about 10%, searching for the level of co-payment
in several pharmacies and 8% of respondents, who had to refuse
dispensation of medicines due to co-payment. CONCLUSIONS:
Our study demonstrates that there are patients who may fail to
access medication due to co-payment. The ﬁnancial participation
on health care costs is generally low in the Czech Republic (8.6%
of total health expenditures) but there were differences in co-
payment levels in patients ranging from 1CZK to thousands
CZK. This might be caused by the absence of any instrument
limiting the individual ﬁnancial participation for example in 12-
month period as in Sweden. In our study co-payments were
lower in smaller communities where respondents reported better
communication between physicians and patients or physicians
and pharmacists.
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OBJECTIVES: Comparison of population health is a matter of
concern for national governments and for international agencies.
This paper reports on the analysis of data collected by in national
surveys conducted in Sweden (S) and England & Wales (EW)
using the same health status questionnaire, administered by post
during 2002 and 2003. METHODS: Data were collected from
1945 respondents in Sweden and 1001 in England & Wales.
Both datasets were weighted to be representative of their respec-
tive national populations. RESULTS: Age-standardised EQ-
5Dvas was systematically higher for men than for women in both
surveys, however this position is reversed for women aged 70+
in the EW survey. Differences in age/gender-standardised EQ-
5Dvas between the 2 national surveys were small (typically <5).
Despite this apparent convergence, the age-standardised rates of
reported problem on the 5 EQ-5D dimensions varied signiﬁ-
cantly both by gender and by survey. The rates of problem on
usual activities, for example, were 2.3% and 6.2% for men and
women aged 20–44 in the Swedish survey. The corresponding
rates in the EW survey were 12.1% and 13.1%. Within-survey
regression models were constructed using EQ-5Dvas as the
dependent variable and recoding the 5 dimensions to 0/1 dummy
variables (no problem/any problem). Both models appear to ﬁt
the data reasonably well (r2 > 0.450) with roughly equivalent
constants (87.9 and 89.5) however, the value decrements given
by the beta coefﬁcients indicate large differences in the impor-
tance associated with each dimension. The highest decrements in
the Swedish survey are for mobility (15.7) and pain/discomfort
(12.0). The highest decrements in the EW survey are for usual
activities (11.4) and anxiety/depression (9.5). CONCLUSION:
The study explores some possible causes of the differences (and
similarities) noted in the analysis and propose a series of stan-
dard tables for use in reporting data on comparative population
health.
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OBJECTIVE: Quality of life (QoL) evaluation allows to under-
stand people’s health state perception and to compare wellbeing
between different (sub)populations. No data with EQ-5D existed
for the Italian population. Our objective was to evaluate QoL 
of the Italian general population aged 40–79 years old.
METHODS: Data was collected from a population-based survey
of people aged 40–79 years. Subjects randomly sampled from
electronic General Practitioners (GP) lists, and accepting to par-
ticipate (16 individuals per GP, with random replacement in case
of refusal), underwent medical examination, blood sampling,
resource utilization interview, and ﬁlled in the EQ-5D. Partici-
pation of GP’s to the EQ-5D sub-study was voluntary. Results
are reported as comparing data of 5th, 6th, 7th and 8th age
decades. RESULTS: A total of 1956 individuals (50.0% males)
from 128 GP’s (approximately half of the invited GP’s partici-
